Source: Milan 2017 - Educational material



Rating:

Share or cite this content

Citations should be made in the following way:
CC7 Pneumonia, pneumonitis, or progressive disease during immunotherapy in lung cancer?. Milan 2017 - Educational material

Member's Comments

No comment yet.

Related content which might interest you: A possible association between breast cancer, bronchiectasis and nontuberculous mycobacterial (NTM) lung disease Source: International Congress 2014 – Resistance, bacteriological profile and comorbidities in respiratory infections Year: 2014 Drug-induced ILD Source: Annual Congress 2007 - PG5 - Interstitial lung diseases: known causes and systemic disorders Year: 2007 Chronic eosinophilic pneumonia after radiation therapy for breast cancer Source: Eur Respir J 2004; 23: 9-13 Year: 2004 Organising pneumonia caused by transtuzumab (Herceptin) therapy for breast cancer Source: Eur Respir J 2003; 21: 552-555 Year: 2003 Treatment of suppurative lung disease Source: ISSN=1025-448x, ISBN=1-904097-33-2, page=168 Year: 2004 Incidence of interstitial lung disease (ILD) and risk factors for developing ILD: A final analysis of a large-scale erlotinib Japanese surveillance study in non-small-cell lung cancer (NSCLC) Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease Year: 2013 Acute exacerbation of idiopathic interstitial pneumonias related to chemotherapy for lung cancer: nationwide surveillance in Japan Source: ERJ Open Res, 6 (2) 00184-2019; 10.1183/23120541.00184-2019 Year: 2020 Pemetrexed in advanced non-small cell lung cancer patients with idiopathic pulmonary fibrosis Source: Annual Congress 2013 –Advances in the therapy of lung cancer Year: 2013 Symptoms and signs of lung cancer Source: Eur Respir Mon; 2009: 44: 71–87 Year: 2009 Canine scent detection in the diagnosis of lung cancer: revisiting a puzzling phenomenon Source: Eur Respir J 2012; 39: 669-676 Year: 2012 The impact of chronic obstructive pulmonary disease on survival of the patients with small-cell lung cancer Source: International Congress 2015 – Diagnosis and therapy of lung cancer Year: 2015 Rituximab for the treatment of chronic hypersensitivity pneumonitis Source: International Congress 2015 – Interstitial lung diseases I Year: 2015 Surfactant protein-D level as a predictor of prognosis of interstitial lung disease induced by anticancer agents in advanced lung cancer Source: International Congress 2016 – Orphan diseases I Year: 2016 Local and systemic neutrophilic inflammation in patients with lung cancer and chronic obstructive pulmonary disease Source: Annual Congress 2013 –Pathogenesis and risk of lung cancer Year: 2013 Novel lung function tests in patients with interstitial lung disease (ILD) Source: International Congress 2016 – Clinical aspects of ILD Year: 2016 Lung cancer is frequently developed in patients with idiopathic interstitial pneumonia Source: Eur Respir J 2007; 30: Suppl. 51, 579s Year: 2007 Mortality and survival predictor in chronic hypersensitivity pneumonitis Source: International Congress 2016 – Sarcoidosis Year: 2016 Treatment and prognosis of lung cancer associated with interstitial pneumonia Source: Annual Congress 2010 - Thoracic malignancies: interesting case studies and series Year: 2010